Logo Logo
Switch Language to German

Modest, D. P.; Jung, A.; Moosmann, N.; Laubender, Rüdiger P.; Giessen, C.; Schulz, C.; Haas, M.; Neumann, J.; Boeck, S.; Kirchner, T.; Heinemann, V. and Stintzing, S. (2012): The influence of KRAS- and BRAF-mutations on the efficacy of cetuximab-based 1st-line therapy of metastatic colorectal cancer: An analysis of the AIO KRK-0104 -trial. In: International Journal of Cancer, Vol. 131, No. 4: pp. 980-986

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item